PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.

PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.

<h4>Background & aims</h4>Aim of this study was to evaluate whether the PNPLA3 I148M polymorphism, previously associated with hepatocellular carcinoma (HCC) risk, influences the clinical presentation of HCC and survival.<h4>Methods</h4>we considered 460 consecutive HCC pa...

Full description

Bibliographic Details
Main Authors:	Luca Valenti, Benedetta Maria Motta, Giorgio Soardo, Massimo Iavarone, Benedetta Donati, Angelo Sangiovanni, Alessia Carnelutti, Paola Dongiovanni, Raffaela Rametta, Cristina Bertelli, Floriana Facchetti, Massimo Colombo, Silvia Fargion, Anna Ludovica Fracanzani
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24155878/pdf/?tool=EBI

Similar Items

The i148m <it>Pnpla3</it> polymorphism influences serum adiponectin in patients with fatty liver and healthy controls
by: Valenti Luca, et al.
Published: (2012-08-01)

Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C.
by: Stella De Nicola, et al.
Published: (2014-01-01)

The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease.
by: Luca Valenti, et al.
Published: (2012-01-01)

The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value
by: Erika Paolini, et al.
Published: (2023-03-01)

Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 Lockdown
by: Felice Cinque, et al.
Published: (2022-01-01)

High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload.
by: Paola Dongiovanni, et al.
Published: (2015-01-01)

PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
by: Salvatore Petta, et al.
Published: (2013-01-01)

Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
by: Daniel Lindén, et al.
Published: (2019-04-01)

Juvenile hemochromatosis associated with heterozygosity for novel hemojuvelin mutations and with unknown cofactors
by: Serena Pelusi, et al.
Published: (2014-09-01)

Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC
by: Paola Dongiovanni, et al.
Published: (2021-10-01)

miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis
by: Paola Dongiovanni, et al.
Published: (2018-12-01)

PD-1/PD-L1 Immuno-Mediated Therapy in NAFLD: Advantages and Obstacles in the Treatment of Advanced Disease
by: Rosa Lombardi, et al.
Published: (2022-02-01)

PNPLA3(I148M) Inhibits Lipolysis by Perilipin-5-Dependent Competition with ATGL
by: Hagen Roland Witzel, et al.
Published: (2022-12-01)

From Environment to Genome and Back: A Lesson from <i>HFE</i> Mutations
by: Raffaela Rametta, et al.
Published: (2020-05-01)

Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids
by: Luukkonen, PK, et al.
Published: (2019)

PNPLA3-I148M Variant Promotes the Progression of Liver Fibrosis by Inducing Mitochondrial Dysfunction
by: Yusong Gou, et al.
Published: (2023-06-01)

A common variant of PNPLA3 (p.I148M) is not associated with alcoholic chronic pancreatitis.
by: Jonas Rosendahl, et al.
Published: (2012-01-01)

PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease
by: Soumik Basu Ray
Published: (2019-01-01)

The rs738409 (I148M) Variant of the PNPLA3 Gene and Type 2 Diabetes in Yakutia
by: Lubov A. Sydykova, et al.
Published: (2018-09-01)

PNPLA3 I148M Up-Regulates Hedgehog and Yap Signaling in Human Hepatic Stellate Cells
by: Francesca Virginia Bruschi, et al.
Published: (2020-11-01)

An association study of the PNPLA3 I148M polymorphism (rs738409) with serum lipids in patients with dyslipidemia
by: Despoina Ioannidou, et al.
Published: (2023-02-01)

AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M
by: Matteo Tardelli, et al.
Published: (2017-11-01)

Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease.
by: Serena Pelusi, et al.
Published: (2016-01-01)

Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease.
by: Anna Ludovica Fracanzani, et al.
Published: (2016-01-01)

The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients
by: Marica Meroni, et al.
Published: (2021-04-01)

Cardiovascular involvement after liver transplantation: role of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
by: Rosa Lombardi, et al.
Published: (2021-02-01)

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
by: Benedetta Donati, et al.
Published: (2017-07-01)

PNPLA3 I148M Variant Impairs Liver X Receptor Signaling and Cholesterol Homeostasis in Human Hepatic Stellate Cells
by: Francesca Virginia Bruschi, et al.
Published: (2019-09-01)

Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China
by: Min Xu, et al.
Published: (2019-05-01)

Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant.
by: Palmer, C, et al.
Published: (2012)

Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant.
by: Colin N A Palmer, et al.
Published: (2012-01-01)

<i>PNPLA3</i> rs738409 Genetic Variant Inversely Correlates with Platelet Count, Thereby Affecting the Performance of Noninvasive Scores of Hepatic Fibrosis
by: Marica Meroni, et al.
Published: (2023-10-01)

PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients
by: Paola Dongiovanni, et al.
Published: (2019-06-01)

Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease.
by: Anna Ludovica Fracanzani, et al.
Published: (2012-01-01)

PNPLA3 148M/M Is More Susceptible to Palmitic Acid-Induced Endoplasmic Reticulum Stress-Associated Apoptosis in HepG2 Cells
by: Yunzhi Chen, et al.
Published: (2023-01-01)

<it>PNPLA 3</it> I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection
by: Rembeck Karolina, et al.
Published: (2012-09-01)

Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease
by: Rosa Lombardi, et al.
Published: (2020-11-01)

Research of <i>PNPLA3</i> I148M Gene Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease, with Liver Cirrhosis and with Hepatocellular Carcinoma
by: V. V. Petkau, et al.
Published: (2023-11-01)

Impact of PNPLA3 p.I148M and Hepatic Steatosis on Long-Term Outcomes for Hepatocellular Carcinoma and HBsAg Seroclearance in Chronic Hepatitis B
by: Hsueh RC, et al.
Published: (2022-04-01)

Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes
by: Marica Meroni, et al.
Published: (2020-02-01)